✦ LIBER ✦

P.02.11 WITHDRAWAL OF INFLIXIMAB (IFX) AFTER ACHIEVING REMISSION: OUTCOME IN A COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS

✍ Scribed by Luppino, I.; Spagnuolo, R.; Marasco, R.; Cosco, C.; Ruggiero, G.; Cosco, V.; Doldo, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P256 Outcome after discontinuation of in

✍ A. Molazahi; C. Steenholdt; M. Ainsworth; J. Brynskov; O. Thomsen; J. Seidelin 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 154 KB

P397 Feasibility and safety of accelerat

✍ Ó. Nantes; C. Rodríguez; M. Basterra; M. Gómez-Alonso; I. Fernández-Urién; B. Ib 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 65 KB

Clinical Correlates of Infliximab (IFX)

✍ Felipez, Lina M. ;Gokhale, Ranjana ;Wroblewski, Kristen ;Godick, Anna ;Kirschner 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Outcome after discontinuation of inflixi

✍ Steenholdt, Casper; Molazahi, Akbar; Ainsworth, Mark Andrew; Brynskov, Jørn; Tho 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 258 KB

1124 Long Term Prognosis After Discontin

✍ Casper Steenholdt; Akbar Molazahi; Mark A. Ainsworth; Jorn Brynskov; Ole Thomsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB

CO31 EFFICACY AND SAFETY OF INFLIXIMAB (

✍ M. Gasparetto; F. Vallortigara; L. Visonà Dalla Pozza; C. Mescoli; M. Cananzi; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB